Autumn Budget 2018

In this report, Brewin Dolphin react to the Chancellor's 2018 Autumn Budget. 
 
Chancellor Philip Hammond heralded that the era of austerity is coming to an end in his third Budget, after discovering he had significantly more money to play with than he had expected.
 
Key points include:
 
- Pensions, savings and estate planning remain largely untouched, Brewin Dolphin regard this reprieve as a good opportunity to make the most of the tax allowances that already exist.
 
- A planned increase in the tax-free personal allowance to £12,500 and higher-rate threshold to £50,000 will take place a year earlier than planned.
 
- The personal allowance is reduced by £1 for every £2 of income above £100,000. This means your allowance is zero if your income is £123,700 or above.




Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.

Click here to download this insight
A Mindset for Continuous Lear...

After recently closing the page on a wide-ranging executive career, following a six-year stint as CFO of FTSE 250 energy business Drax, Criticaleye Senior Editor Jacob Ambrose Willson finds Andy Skelton in a reflective ...

Inspiring Leaders Podcast: H...

Hosted by Marc Barber, Director of Content, Christopher Boerger, CFO of E.ON UK, he reflects on the role CFOs play in innovation and growth within a company. He explores the mindset required to succeed, which is based o...

Click here to download this insight
Accelerating CFO Success

Criticaleye has over 21 years of experience transforming global leaders including aspiring Chief Financial Officers, supporting on a range of challenges including making a valuable contribution to strategic development,...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 165




NatWest Group FTSE Women Leaders Review Drax Group plc Aldermore Group Worldpay Workday Concentrix British Land Google Palo Alto Networks Lightsource bp NATS Eightfold AI Salesforce Hitachi Solutions London Stock Exchange Group Accenture Rolls-Royce Legal & General GlaxoSmithKline plc AlixPartners E.ON UK IBM Consulting